iRhythm Technologies Inc Asset Resilience Ratio
iRhythm Technologies Inc asset resilience ratio. iRhythm Technologies Inc (IRTC) has an Asset Resilience Ratio of 30.75% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See iRhythm Technologies Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of iRhythm Technologies Inc (2015–2025)
Asset resilience ratio of iRhythm Technologies Inc from 2015 to 2025. This chart shows how iRhythm Technologies Inc's Asset Resilience Ratio has changed over time. Read iRhythm Technologies Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down iRhythm Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see iRhythm Technologies Inc asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $309.47 Million | 30.75% |
| Total Liquid Assets | $309.47 Million | 30.75% |
Asset Resilience Insights
- Very High Liquidity: iRhythm Technologies Inc maintains exceptional liquid asset reserves at 30.75% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
iRhythm Technologies Inc Industry Peers by Asset Resilience Ratio
Compare iRhythm Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
iRhythm Technologies Inc Asset Resilience Ratio by Year (2015–2025)
iRhythm Technologies Inc asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for iRhythm Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 34.09% | $347.75 Million | $1.02 Billion | +21.64pp |
| 2024-12-31 | 12.45% | $115.96 Million | $931.45 Million | -10.08pp |
| 2023-12-31 | 22.53% | $97.59 Million | $433.14 Million | -7.43pp |
| 2022-12-31 | 29.97% | $134.31 Million | $448.22 Million | +5.87pp |
| 2021-12-31 | 24.10% | $111.57 Million | $462.97 Million | -24.09pp |
| 2020-12-31 | 48.19% | $246.59 Million | $511.74 Million | +8.97pp |
| 2019-12-31 | 39.22% | $120.09 Million | $306.21 Million | -9.50pp |
| 2018-12-31 | 48.72% | $58.32 Million | $119.71 Million | -21.66pp |
| 2017-12-31 | 70.38% | $93.69 Million | $133.12 Million | +31.00pp |
| 2016-12-31 | 39.38% | $54.41 Million | $138.16 Million | +39.14pp |
| 2015-12-31 | 0.24% | $91.00K | $37.87 Million | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more